Biomarker Qualification Decision Letter

First Page		Document Content
Biomarkers Biotechnology Chemical pathology Clusterin Kidney Collecting duct system Nephrotoxicity Norfloxacin Imaging biomarker Medicine Biology Nephrology		Biomarker Qualification Decision Letter Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 233,28 KB Share Document on Facebook

	Original Article The Modulatory Role of Ashwagandha Root Extract on Gamma-Radiation-Induced Nephrotoxicity and Cardiotoxicity in Male Albino Rats DocID: 1qKqD - View Document
	NGAL STRONG EVIDENCE SUPPORTS NGAL AS A KIDNEY BIOMARKER THE NGAL BRIDGE DocID: 1aIBp - View Document
	Appendix XIII Detection of Aristolochic Acid I Appendix XIII: Detection of Aristolochic Acid I Aristolochic Acid I (AAI) is a known nephrotoxin and potential carcinogen that is commonly present in herbs derived from pla DocID: 17Idg - View Document
	Paediatric Drug Dosage Adjustments in Patients with Renal Impairment or on Renal Replacement Therapies for use on the Intensive Care and Renal Units DocID: 15ujS - View Document
	Acute Kidney Injury Andrew Lunn Consultant Paediatric Nephrologist Overview DocID: 15cHy - View Document